NZ745324A - Vaccines and vaccine components for inhibition of microbial cells - Google Patents

Vaccines and vaccine components for inhibition of microbial cells

Info

Publication number
NZ745324A
NZ745324A NZ745324A NZ74532408A NZ745324A NZ 745324 A NZ745324 A NZ 745324A NZ 745324 A NZ745324 A NZ 745324A NZ 74532408 A NZ74532408 A NZ 74532408A NZ 745324 A NZ745324 A NZ 745324A
Authority
NZ
New Zealand
Prior art keywords
vaccines
seq
inhibition
microbial cells
vaccine components
Prior art date
Application number
NZ745324A
Other languages
English (en)
Inventor
Eric Heinz Altermann
Graeme Trevor Attwood
Dong Li
William John Kelly
Zhanhao Kong
Sinead Christine Leahy
Original Assignee
Pastoral Greenhouse Gas Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pastoral Greenhouse Gas Res Ltd filed Critical Pastoral Greenhouse Gas Res Ltd
Priority to NZ780936A priority Critical patent/NZ780936B2/en
Priority claimed from NZ728409A external-priority patent/NZ728409A/en
Publication of NZ745324A publication Critical patent/NZ745324A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/20—Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
    • Y02P60/22—Methane [CH4], e.g. from rice paddies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
NZ745324A 2007-09-25 2008-09-25 Vaccines and vaccine components for inhibition of microbial cells NZ745324A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ780936A NZ780936B2 (en) 2008-09-25 Vaccines and vaccine components for inhibition of microbial cells

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US97510407P 2007-09-25 2007-09-25
US98984007P 2007-11-22 2007-11-22
US98984107P 2007-11-22 2007-11-22
NZ728409A NZ728409A (en) 2007-09-25 2008-09-25 Vaccines and vaccine components for inhibition of microbial cells

Publications (1)

Publication Number Publication Date
NZ745324A true NZ745324A (en) 2023-02-24

Family

ID=40511642

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ745324A NZ745324A (en) 2007-09-25 2008-09-25 Vaccines and vaccine components for inhibition of microbial cells

Country Status (17)

Country Link
US (7) US9296789B2 (OSRAM)
EP (5) EP2203467B1 (OSRAM)
JP (5) JP5552053B2 (OSRAM)
CN (4) CN101918431B (OSRAM)
AR (3) AR068553A1 (OSRAM)
AU (4) AU2008304019A1 (OSRAM)
BR (5) BR122021010737B1 (OSRAM)
CA (3) CA2700162C (OSRAM)
CL (3) CL2008002861A1 (OSRAM)
DK (3) DK3327030T3 (OSRAM)
ES (3) ES2625144T3 (OSRAM)
MX (3) MX2010003321A (OSRAM)
NZ (1) NZ745324A (OSRAM)
RU (1) RU2528854C2 (OSRAM)
UY (3) UY31360A1 (OSRAM)
WO (3) WO2009041832A2 (OSRAM)
ZA (1) ZA201001933B (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2625144T3 (es) * 2007-09-25 2017-07-18 Pastoral Greenhouse Gas Research Ltd Polinucleótidos y polipéptidos del fargo MRU y usos de éstos
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
ES2579806T3 (es) * 2009-06-26 2016-08-16 Katholieke Universiteit Leuven, K.U. Leuven R&D Agentes antimicrobianos
SG177704A1 (en) * 2009-06-26 2012-02-28 Lysando Holding Ag Antimicrobial agents
UY32866A (es) * 2009-08-27 2011-03-31 Pastoral Greenhouse Gas Res Ltd Secuencia genómica completa del metanógeno methanobrevibacter ruminantium
EA037276B1 (ru) * 2010-04-27 2021-03-03 Лисандо Аг Способы устранения или уменьшения бактериальной биопленки
CN104837859B (zh) * 2012-09-19 2019-02-22 珍白斯凯尔有限公司 细胞穿透肽、包含该肽的缀合物、及包含该缀合物的组合物
EP4234696A3 (en) * 2012-12-12 2023-09-06 The Broad Institute Inc. Crispr-cas component systems, methods and compositions for sequence manipulation
KR102874079B1 (ko) 2013-03-15 2025-10-22 더 제너럴 하스피탈 코포레이션 Rna-안내 게놈 편집을 위해 특이성을 증가시키기 위한 절단된 안내 rna(tru-grnas)의 이용
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
US10011850B2 (en) 2013-06-21 2018-07-03 The General Hospital Corporation Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing
KR20230054509A (ko) 2013-11-07 2023-04-24 에디타스 메디신, 인코포레이티드 지배적인 gRNA를 이용하는 CRISPR-관련 방법 및 조성물
KR102424721B1 (ko) * 2014-11-06 2022-07-25 이 아이 듀폰 디 네모아 앤드 캄파니 Rna-유도 엔도뉴클레아제의 세포 내로의 펩티드 매개성 전달
CN104789675A (zh) * 2015-04-15 2015-07-22 江苏师范大学 一种检测荷斯坦奶牛瘤胃微生物的方法
US11845928B2 (en) * 2015-05-04 2023-12-19 Tsinghua University Methods and kits for fragmenting DNA
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US20190292514A1 (en) * 2016-07-14 2019-09-26 Basf Se Fermentation medium comprising chelating agent
EP3565904A1 (en) * 2016-12-29 2019-11-13 Illumina, Inc. Analysis system for orthogonal access to and tagging of biomolecules in cellular compartments
CN112986589B (zh) * 2017-01-05 2023-01-24 深圳迈瑞生物医疗电子股份有限公司 网织红细胞模拟粒子、血小板模拟粒子制备方法及质控物
US10745439B2 (en) * 2017-03-20 2020-08-18 Regents Of The University Of Minnesota Kinase substrates and methods of use thereof
US20190233816A1 (en) 2018-01-26 2019-08-01 Massachusetts Institute Of Technology Structure-guided chemical modification of guide rna and its applications
CN111885915B (zh) * 2018-03-19 2023-04-28 瑞泽恩制药公司 使用crispr/cas系统对动物进行转录调制
JP7619941B2 (ja) 2018-11-14 2025-01-22 アイバイオ， インク． Ｃｄ２５抗体
CN113646330A (zh) 2018-11-14 2021-11-12 鲁比克治疗股份有限公司 工程化cd25多肽及其用途
CN109627301B (zh) * 2019-02-18 2022-08-05 浙江新银象生物工程有限公司 Nisin固体稳定剂开发及应用
EP4121001A1 (en) * 2020-03-19 2023-01-25 Micreos Human Health B.V. A stabilized protein of interest
US20230072496A1 (en) * 2020-04-10 2023-03-09 Liberty Biosecurity, Llc Polypeptide compositions and uses thereof
CN112143747B (zh) * 2020-09-09 2022-09-13 昆明理工大学 一种噬菌体裂解酶及其基因、基因重组表达载体与应用
CA3201057A1 (en) 2020-12-08 2022-06-16 Mark Christopher LAY Improvements to devices and methods for delivery of substances to animals
CN112961217B (zh) * 2021-03-19 2022-11-08 江苏元本生物科技有限公司 一种靶向Siglec-15的噬菌体多肽
CN113121705B (zh) * 2021-04-19 2023-03-24 成都英普博集生物科技有限公司 用于制备短肽混合物的融合蛋白、目的多肽、短肽混合物的制备方法及应用
CA3261760A1 (en) * 2022-07-11 2024-01-18 Arkea Bio Corp COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS
CN115417927A (zh) * 2022-09-08 2022-12-02 南京松天盛科生物科技有限公司 小鼠腹水致敏物及其应用
IL319970A (en) * 2022-11-03 2025-05-01 Helix Nanotechnologies Inc Ruminal and methanogen vaccines and their uses
CN115938486B (zh) * 2022-12-06 2023-11-10 内蒙古农业大学 基于图神经网络的抗菌性乳酸菌株筛选方法
WO2025219570A1 (en) 2024-04-17 2025-10-23 Johannes Kepler Universität Linz Composition for inhibiting protein translocation and methods using the same
WO2025233675A1 (en) * 2024-05-10 2025-11-13 Institut Pasteur Use of talosaminidase to regulate populations of archaeal methanogens in industrial, agricultural and medical settings

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US159861A (en) * 1875-02-16 Improvement in brooms
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
CA1221635A (fr) * 1983-05-03 1987-05-12 Andre Speecke Composition a activite pharmaceutique amelioree et utilisation de celle-ci pour des usages veterinaires
GB8815968D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Veterinary devices
JPH05219927A (ja) * 1992-02-14 1993-08-31 Gumma Pref Gov 飼料の混合装置及び混合飼料の製造方法
JP3651915B2 (ja) * 1993-06-30 2005-05-25 財団法人神奈川科学技術アカデミー シグナル配列ペプチドをコードするｄｎａ断片の探索法及びそのためのベクター
DE69433645T2 (de) * 1993-10-19 2005-03-10 Commonwealth Scientific And Industrial Research Organisation Methode zur verbesserung der nahrungsverwertung von wiederkäuern oder wiederkäuer-ähnlichen tieren
AU8126694A (en) 1993-10-26 1995-05-22 Affymax Technologies N.V. Arrays of nucleic acid probes on biological chips
DE69531773T2 (de) 1994-01-20 2004-07-15 Agresearch Ltd. Vorrichtung zur verabreichung von nützlichen stoffen an wiederkäuer
NZ278977A (en) 1994-01-20 1997-03-24 Pastoral Agric Res Inst Nz Ltd Sustained release bolus for ruminants
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
AUPN353695A0 (en) 1995-06-14 1995-07-06 Commonwealth Scientific And Industrial Research Organisation Immunogenic preparation and method for improving the productivity of ruminant animals
US6503729B1 (en) * 1996-08-22 2003-01-07 The Board Of Trustees Of The University Of Illinois Selected polynucleotide and polypeptide sequences of the methanogenic archaeon, methanococcus jannashii
US5985907A (en) * 1998-08-12 1999-11-16 Health Research, Inc. Method for inhibiting growth of methanogens
WO2002077183A2 (en) 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
US20030219467A1 (en) * 2001-09-18 2003-11-27 The Board Of Regents Of The University Of Nebraska Method for the inhibition of methanogensis
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
AU2003222249A1 (en) * 2002-03-04 2003-09-22 Fidelity Systems, Inc., Et Al. The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof
SE523209C2 (sv) * 2002-05-14 2004-04-06 Akzo Nobel Nv Förfarande för att reducera metanbildningen från matspjälkningsaktiviteter hos djur
EP1861490A4 (en) 2005-03-23 2010-11-17 Univ St Louis USE OF ARRAYS TO MODULATE NUTRIENT CAPTURE FUNCTIONS BY THE GASTROINTESTINAL MICROBIOTE
ES2625144T3 (es) * 2007-09-25 2017-07-18 Pastoral Greenhouse Gas Research Ltd Polinucleótidos y polipéptidos del fargo MRU y usos de éstos
CN101434924A (zh) * 2008-12-17 2009-05-20 中南大学 一种分离严格厌氧产甲烷古菌的方法
UY32866A (es) * 2009-08-27 2011-03-31 Pastoral Greenhouse Gas Res Ltd Secuencia genómica completa del metanógeno methanobrevibacter ruminantium
CN101864362B (zh) * 2010-05-19 2012-05-09 江苏加德绿色能源有限公司 一种复合微生物菌剂及其应用
DE102011119230B4 (de) * 2011-11-23 2013-07-11 Audi Ag Kraftwagen-Blinkleuchte und Verfahren zum Betreiben einer Blinkleuchte
BR112015014843A2 (pt) * 2012-12-21 2017-10-10 Danisco Us Inc produção de isopreno, isoprenoide, e precursores de isoprenoide usando uma via de mevalonato inferior alternativa

Also Published As

Publication number Publication date
EP2203466B1 (en) 2016-04-06
EP2203466A2 (en) 2010-07-07
MX340736B (es) 2016-07-22
AU2014210649B2 (en) 2016-09-08
DK2203467T3 (en) 2017-03-27
EP2203467A1 (en) 2010-07-07
CA2700164C (en) 2018-05-29
RU2528854C2 (ru) 2014-09-20
BR122021010729B1 (pt) 2022-02-15
US20100209998A1 (en) 2010-08-19
AU2014210649A1 (en) 2014-09-04
AU2008305846A1 (en) 2009-04-02
JP2010539926A (ja) 2010-12-24
CN107129524A (zh) 2017-09-05
BR122021010737B1 (pt) 2021-09-21
US10995120B2 (en) 2021-05-04
WO2009041832A3 (en) 2009-06-11
EP3327030B1 (en) 2021-07-21
NZ780936A (en) 2024-08-30
BRPI0817299A8 (pt) 2019-01-29
BRPI0817312A2 (pt) 2015-03-17
WO2009041831A1 (en) 2009-04-02
US20100221185A1 (en) 2010-09-02
DK2203466T3 (en) 2016-07-25
WO2009041832A9 (en) 2009-10-22
EP2203470A4 (en) 2011-04-13
US20140220636A1 (en) 2014-08-07
WO2009041830A9 (en) 2009-08-27
ZA201001933B (en) 2013-10-30
BRPI0817299A2 (pt) 2015-06-16
EP3936516A1 (en) 2022-01-12
WO2009041831A9 (en) 2009-11-05
US20210332087A1 (en) 2021-10-28
JP2015042166A (ja) 2015-03-05
ES2895908T3 (es) 2022-02-23
BR122020023381B1 (pt) 2021-09-08
JP6067209B2 (ja) 2017-01-25
US20170342112A1 (en) 2017-11-30
WO2009041830A2 (en) 2009-04-02
US20100209999A1 (en) 2010-08-19
AU2008304019A1 (en) 2009-04-02
AR068552A1 (es) 2009-11-18
MX2010003328A (es) 2010-08-16
RU2010116163A (ru) 2011-11-10
AR068553A1 (es) 2009-11-18
EP2203466A4 (en) 2011-04-13
MX2010003319A (es) 2010-09-10
EP2203467B1 (en) 2016-12-14
JP2010539928A (ja) 2010-12-24
CA2700129A1 (en) 2009-04-02
UY31359A1 (es) 2009-04-30
US8592556B2 (en) 2013-11-26
ES2587595T3 (es) 2016-10-25
AR068551A1 (es) 2009-11-18
AU2008304018A1 (en) 2009-04-02
ES2625144T3 (es) 2017-07-18
US11926647B2 (en) 2024-03-12
US9296789B2 (en) 2016-03-29
MX2010003321A (es) 2010-08-03
CA2700129C (en) 2021-07-20
CN101918431B (zh) 2014-10-08
WO2009041830A3 (en) 2009-07-02
CA2700162A1 (en) 2009-04-02
CN107129524B (zh) 2023-11-21
DK3327030T3 (da) 2021-10-04
US10590170B2 (en) 2020-03-17
CL2008002861A1 (es) 2009-03-06
EP2203467A4 (en) 2011-04-13
UY31360A1 (es) 2009-04-30
BRPI0817312B1 (pt) 2018-05-29
EP2203470A2 (en) 2010-07-07
CN101932595B (zh) 2016-02-10
JP5558356B2 (ja) 2014-07-23
JP2017046704A (ja) 2017-03-09
US20200325180A1 (en) 2020-10-15
US8586709B2 (en) 2013-11-19
CA2700164A1 (en) 2009-04-02
CN101932595A (zh) 2010-12-29
CN101918431A (zh) 2010-12-15
JP2010539927A (ja) 2010-12-24
CA2700162C (en) 2018-08-14
CL2008002860A1 (es) 2009-06-05
UY31361A1 (es) 2009-04-30
JP5552053B2 (ja) 2014-07-16
EP3327030A1 (en) 2018-05-30
CL2008002859A1 (es) 2009-03-06
CN102015755A (zh) 2011-04-13
WO2009041832A2 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
NZ745324A (en) Vaccines and vaccine components for inhibition of microbial cells
NZ750559A (en) Complete genome sequence of the methanogen methanobrevibacter ruminantium
TW201129379A (en) Anti-Orai1 antigen binding proteins and uses thereof
PH12012500849A1 (en) Mycobacterial vaccines
MX375379B (es) Receptores de celulas t anti - papilomavirus 16 e7 humano.
NZ607224A (en) Non-lipidated variants of neisseria meningitidis orf2086 antigens
MX387465B (es) Marcas genéticas de transgenes y métodos de uso.
CA2848209C (en) T cell receptors recognizing hla-a1- or hla-cw7-restricted mage
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
MX358725B (es) Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden.
WO2009130618A3 (en) Flagellin polypeptide vaccines
NZ601438A (en) Immunotherapy against several tumors including gastrointestinal and gastric cancer
WO2007130455A3 (en) Compositions and methods for treatment of non-hodgkins lymphoma
UA110806C2 (uk) Мікобактеріальна антигенна композиція
PE20140986A1 (es) Proteinas de fusion y vacunas de combinacion que comprenden proteina e y pilina a de haemophilus influenzae
NZ585777A (en) Compositions and methods of enhancing immune responses to eimeria
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
UA107330C2 (uk) Туберкульозний білок rv3616c та його застосування
EA201390820A1 (ru) Слитый белок против рака
MX377650B (es) Vacuna y métodos para reducir una infección por campylobacter.
NZ629309A (en) Tumour necrosis factor receptor fusion proteins and methods of using the same
NZ596501A (en) Casb7439 constructs
PH12017502080A1 (en) Epidermal growth factor receptor variant iii-mesothelin fusions and methods of using the same
NZ601980A (en) Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
NZ591133A (en) Novel melanoma antigen peptide and uses thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 16 YEARS UNTIL 25 SEP 2028 BY SOUTHERN CROSS INTELLECTUAL PROPERTY LIMITED

Effective date: 20230620

ASS Change of ownership

Owner name: LUCIDOME BIO LIMITED, NZ

Effective date: 20250416